Flow cytometric evaluation of apoptosis on the effect of mirazid on gentamicin-induced renal damage in rats
DOI:
https://doi.org/10.54987/jobimb.v2i1.124Abstract
The present study evaluates the effect of mirazid (mz) cd95 and cell cycle in rats of gentamicin (gm) induced renal damage for the detection of apoptosis. Albino male rats (rattus norvegicus), weighing 40–50 g were divided into 6 groups; normal saline, orally treated mirazid 10 mg/kg, gm i.p) for 10 days, mz at 2.5, 5, and 10 mg/kg, per oral for 10 days with the same concentration of gm, mz administered concurrently with gm for 10 days. Gm treatment caused nephrotoxicity as evidenced by marked elevation in serum creatinine and urea (152.3 ± 8.6 mg/dl, 1.6 ± 0.12 mg/dl resp) when compared to the saline treated group. Gm cause significant increase in both sub g1 (apoptosis) and cd95, marker of apoptosis, when compared to saline control whereas mz give significant decrease in cd95 (fas and fas ligand detection) and sub g1 (apoptosis).
References
Swain RA, Kaplan-Machlis B. Therapeutic uses of vitamin E in prevention of atherosclerosis. Altern Med Rev. 1999;4(6):414–23.
Al-Majed AA, Mostafa AM, Al-Rikabi AC, Al-Shabanah OA. Protective effects of oral arabic gum administration on gentamicin-induced nephrotoxicity in rats. Pharmacol Res. 2002;46(5):445–51.
Mingeot-Leclercq M-P, Tulkens PM. Aminoglycosides: Nephrotoxicity. Antimicrob Agents Chemother. 1999;43(5):1003–12.
Begg EJ, Barclay ML. Aminoglycosides - 50 years on. Br J Clin Pharmacol. 1995;39(6):597–603.
Edson RS, Terrell CL. The aminoglycosides. Mayo Clin Proc. 1999;74(5):519–28.
Reiter RJ, Tan D-X, Sainz RM, Mayo JC, Lopez-Burillo S. Melatonin: Reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol. 2002;54(10):1299–321.
Erdem A, Gündoǧan NU, Usubütün A, Kilinç K, Erdem SR, Kara A, et al. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol Dial Transplant. 2000;15(8):1175–82.
Rougier F, Claude D, Maurin M, Maire P. Aminoglycoside nephrotoxicity. Curr Drug Targets - Infect Disord. 2004;4(2):153–62.
Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di Paola R, Britti D, et al. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol. 2002;450(1):67–76.
Halliwell B, Gutteridge JMC. Free Radicals in Biologyand Medicine. Oxford, U.K.: Clarendon Press; 1999.
Greene DA. Gold, frankincense, myrrh, and medicine. N C Med J. 1993;54(12):620–2.
Michie CA, Cooper E. Frankincense and myrrh as remedies in children. J R Soc Med. 1991;84(10):602–5.
Moran J, Addy M, Roberts S. A comparison of natural product, triclosan and chlorhexidine mouthrinses on 4-day plaque regrowth. J Clin Periodontol. 1992;19(8):578–82.
Badria F, Abou-Mohamed G, El-Mowafy A, Masoud A, Salama O. Mirazid: A new schistosomicidal drug. Pharm Biol. 2001;39(2):127–31.
Sheir Z, Nasr AA, Massoud A, Salama O, Badra GA, El-Shennawy H, et al. A safe, effective, herbal antischistosomal therapy derived from myrrh. Am J Trop Med Hyg. 2001 Dec;65(6):700–4.
Abo-Madyan AA, Morsy TA, Motawea SM. Efficacy of Myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El-Fayoum Governorate, Egypt. J Egypt Soc Parasitol. 2004;34(2):423–46.
Hanan FA. Evaluation of antioxidants effect of Citrus reticulata in Schistosoma mansoni infected mice. Trends Med Res. 2007 Jan 1;2(1):37–43.
Aebi HE. Assays of catalase in vitro. In: (Parker L. ed.), Academic Press, NY, p., 122–126. In: Parker L, editor. Methods in enzymology. New York: Academic Press; 1984. p. 122–6.
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158–69.
Nishikimi M, Appaji Rao N, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun. 1972;46(2):849–54.
Lim P-S, Wang N-P, Lu T-C, Wang T-H, Hsu W-M, Chan EC, et al. Evidence for alterations in circulating low-molecular-weight antioxidants and increased lipid peroxidation in smokers on hemodialysis. Nephron. 2001;88(2):127–33.
Shifow AA, Kumar KV, Naidu MUR, Ratnakar KS. Melatonin, a pineal hormone with antioxidant property, protects against gentamicin-induced nephrotoxicity in rats. Nephron. 2000;85(2):167–74.
Parlakpinar H, Tasdemir S, Polat A, Bay-Karabulut A, Vardi N, Ucar M, et al. Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. Toxicology. 2005 Feb 14;207(2):169–77.
Yaman I, Balikci E. Protective effects of nigella sativa against gentamicin-induced nephrotoxicity in rats. Exp Toxicol Pathol Off J Ges Für Toxikol Pathol. 2010;62(2):183–90.
Pai PG, Chamari Nawarathna S, Kulkarni A, Habeeba U, Reddy C. S, Teerthanath S, et al. Nephroprotective Effect of Ursolic Acid in a Murine Model of Gentamicin-Induced Renal Damage. ISRN Pharmacol Internet.. 2012 cited 2015 Oct 13.;2012. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394390/
Guidet BR, Shah SV. In vivo generation of hydrogen peroxide by rat kidney cortex and glomeruli. Am J Physiol - Ren Fluid Electrolyte Physiol. 1989;256(1).
Humes HD, Wenberg JM. Toxic nephropathies. In: Brener BM, Rector FCJ, editors. The Kidney. Philadelphia: WB Saunders Co; 1986. p. 491–532.
Hickey EJ, Raje RR, Reid VE, Gross SM, Ray SD. Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med. 2001;31(2):139–52.
Abdel-Zaher AO, Abdel-Rahman MM, Hafez MM, Omran FM. Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage. Toxicology. 2007;234(1-2):124–34.
Vijay Kumar K, Naidu MUR, Shifow AA, Ratnakar KS. Probucol protects against gentamicin-induced nephrotoxicity in rats. Indian J Pharmacol. 2000;32(2):108–13.
El-Rigal N-S, Hetta MH. Effect of Citrus reticulata on Serum protein fractions of mice after Schistosoma mansoni infection. J Appl Sci. 2006;6(7):1447–55.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).